Understanding Diabetic Crises: Prevalence and Costs in Low-Income Nations

Understanding Diabetic Crises: Prevalence and Costs in Low-Income Nations

Diabetic emergencies remain a significant healthcare challenge in developing countries, presenting a complex intersection of medical, social, and economic issues. This systematic review highlights the concerning prevalence and impact of acute diabetic complications in resource-limited settings.

Metformin and Mediterranean Diet: A Strategy for Preventing Diabetes in Metabolic Syndrome

Metformin and Mediterranean Diet: A Strategy for Preventing Diabetes in Metabolic Syndrome

The MeMeMe randomized trial studied whether metformin (1,700 mg/day), with or without a Mediterranean diet (MedDiet), could reduce the incidence of major noncommunicable diseases (NCDs) in individuals with metabolic syndrome (MetS). The trial included 1,442 participants, randomly assigned to one of four groups: metformin alone, metformin + MedDiet, placebo alone, or placebo + MedDiet. The participants were followed for an average of three years, with the primary outcome being the cumulative incidence of type 2 diabetes, cardiovascular diseases, and cancer.

Rising Diabetes Burden in Adolescents: A 30-Year Global Analysis of Type 1 and Type 2 Diabetes with Projections to 2030

Rising Diabetes Burden in Adolescents: A 30-Year Global Analysis of Type 1 and Type 2 Diabetes with Projections to 2030

The study provides a comprehensive analysis of diabetes trends among adolescents aged 10–24 years. Using data from the Global Burden of Disease (GBD) 2021 study, it estimates the prevalence, disability-adjusted life years (DALYs), and risk factors for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) across 204 countries and territories. The findings reveal a significant increase in the global burden of adolescent diabetes, with 3.4 million living with T1DM and 14.6 million with T2DM in 2021. By 2030, these numbers are projected to rise to 3.7 million and 20.9 million, respectively.